Night Owl Metabolism

计划入组 70 人 · 首次发布于 2024 年 7 月 18 日

Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)

计划入组 187 人 · 首次发布于 2024 年 1 月 5 日

Trypan Blue Versus Brillant Blue for Epiretinal Membranes

计划入组 60 人 · 首次发布于 2008 年 9 月 23 日

OWL-1023

OWL-4130

OWL-1975

BLUE CARIBE, INC.

United States

Blue Marble Rehab Inc.

United States

Blue Earth Therapeutics Ltd.

United Kingdom

ITM Secures $262.5M Debt Financing to Support Commercial Launch of Radiopharmaceutical ITM-11 Following Positive Phase 3 Results

BridgeBio Secures $300 Million Royalty Financing to Support ATTR-CM Drug Launch

Eagle Pharmaceuticals Secures $69 Million Deal to Monetize BENDEKA Royalties